Prelude Therapeutics Inc
Recent Filings
All 358 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Combs Andrew | Chief Chemistry Officer | Purchase | 100,000 @ $0.69 | Mar 25, 2025 |
| Vaddi Krishna | CEO | Purchase | 675,000 @ $0.69 | Mar 25, 2025 |
| Vaddi Krishna | CEO | Purchase | 15,000 @ $0.73 | Mar 20, 2025 |
| Vaddi Krishna | CEO | Purchase | 29,999 @ $0.75 | Mar 17, 2025 |
| Vaddi Krishna | CEO | Purchase | 50,000 @ $0.72 | Mar 12, 2025 |
| Vaddi Krishna | CEO | Purchase | 5,000 @ $1.21 | Dec 31, 2024 |
| Vaddi Krishna | CEO | Purchase | 10,000 @ $1.20 | Dec 30, 2024 |
| Combs Andrew | Chief Chemistry Officer | Purchase | 60,000 @ $1.37 | Dec 20, 2024 |
| Lim Bryant David | CLO, Interim CFO, Corp Sec. | Purchase | 25,000 @ $0.91 | Dec 19, 2024 |
| Vaddi Krishna | CEO | Purchase | 6,888 @ $0.89 | Dec 18, 2024 |